Drawing for NEURELLA

USPTO serial 87229617

NEURELLA

Reviewed by CopyMark Law Group

Reg. 5308243Status 705Renewal
Filing date
Status date
Registration date
Oct 10, 2017
Examiner
MARTIN, LIEF ANDREW
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with NEURELLA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Pesochinsky

Michael Pesochinsky www.mybrandmark.com9 Warner WayWayne, NJ 07470UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements for brain optimization and wellnessACTIVEMay 26, 2017
044[ Providing information about dietary supplements and nutrition ]SECTION 8 - CANCELLEDMay 26, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 22, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 22, 2024C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 22, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 29, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Oct 10, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 10, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 7, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 6, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 12, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 12, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 18, 2017IUAFUSE AMENDMENT FILED—
Jul 18, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 30, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 4, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 15, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 15, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 15, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 15, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 15, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 15, 2017DOCKASSIGNED TO EXAMINER—
Nov 14, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance